InvestorsHub Logo
Followers 11
Posts 546
Boards Moderated 0
Alias Born 08/18/2017

Re: None

Wednesday, 10/20/2021 11:10:24 PM

Wednesday, October 20, 2021 11:10:24 PM

Post# of 704626
Orbis

Feb 16 2021 FDA grants priority review to Amgen’s Sotorasib. https://investors.amgen.com/node/30871/pdf

Sept 13 2021 “Amgen’s first-in-class medicine Lumykras (sotorasib) has become the first new cancer therapy to receive Conditional Marketing Authorisation for use1 across England, Scotland and Wales by the Medicines and Healthcare products Regulatory Agency (MHRA) under Project Orbis.”

https://pharmafield.co.uk/pharma_news/amgens-lumykras-gains-mhra-approval-under-project-orbis/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News